Biomea Fusion Statistics

Total Valuation

Biomea Fusion has a market cap or net worth of $181.16 million. The enterprise value is $46.97 million.

Market Cap	181.16M
Enterprise Value	46.97M

Important Dates

The next estimated earnings date is Monday, July 29, 2024, after market close.

Earnings Date	Jul 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Biomea Fusion has 35.94 million shares outstanding. The number of shares has increased by 21.31% in one year.

Shares Outstanding	35.94M
Shares Change (YoY)	+21.31%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	25.14%
Owned by Institutions (%)	76.63%
Float	19.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.34
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.84, with a Debt / Equity ratio of 0.08.

Current Ratio	5.84
Quick Ratio	n/a
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.90% and return on invested capital (ROIC) is -93.69%.

Return on Equity (ROE)	-69.90%
Return on Assets (ROA)	-60.40%
Return on Capital (ROIC)	-93.69%
Revenue Per Employee	n/a
Profits Per Employee	-$1.24M
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.43% in the last 52 weeks. The beta is -0.55, so Biomea Fusion's price volatility has been lower than the market average.

Beta (5Y)	-0.55
52-Week Price Change	-76.43%
50-Day Moving Average	7.67
200-Day Moving Average	12.33
Relative Strength Index (RSI)	41.27
Average Volume (20 Days)	1,089,479

Short Selling Information

The latest short interest is 7.84 million, so 21.82% of the outstanding shares have been sold short.

Short Interest	7.84M
Short Previous Month	11.79M
Short % of Shares Out	21.82%
Short % of Float	40.32%
Short Ratio (days to cover)	3.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-137.16M
Pretax Income	-127.27M
Net Income	-127.27M
EBITDA	-122.55M
EBIT	-127.27M
Earnings Per Share (EPS)	-$3.57

Full Income Statement

Balance Sheet

The company has $145.29 million in cash and $11.09 million in debt, giving a net cash position of $134.20 million or $3.73 per share.

Cash & Cash Equivalents	145.29M
Total Debt	11.09M
Net Cash	134.20M
Net Cash Per Share	$3.73
Equity (Book Value)	135.31M
Book Value Per Share	3.76
Working Capital	122.31M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$104.58 million and capital expenditures -$499,000, giving a free cash flow of -$105.08 million.

Operating Cash Flow	-104.58M
Capital Expenditures	-499,000
Free Cash Flow	-105.08M
FCF Per Share	-$2.93

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biomea Fusion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.31%
Shareholder Yield	-21.31%
Earnings Yield	-70.25%
FCF Yield	-58.00%

Analyst Forecast

The average price target for Biomea Fusion is $26.63, which is 428.37% higher than the current price. The consensus rating is "Buy".

Price Target	$26.63
Price Target Difference	428.37%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3